CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00780143
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:06.149102+00:00
Published At: 2018-11-09T00:00:00+00:00
Record Updated At: 2018-11-09
Results Posted At: 2018-11-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Relapsed/Refractory Leukemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-11-09"
protocolSection.identificationModule.nctId: "NCT00780143"
protocolSection.identificationModule.officialTitle: "Phase I/II Study of Plitidepsin (Aplidin\u00ae) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-11-09"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.